Holen Sie sich die Stockscreener-App
0.83
2.70%
0.0218
Handel nachbörslich:
.81
-0.02
-2.41%
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
bioAffinity Technologies’ Quarterly CyPath® Lung Sales Double to New Record as Commercial Momentum Continues - BioSpace
bioAffinity Technologies Sets New Record as CyPath® Lung Sales Double with Over 200% Year-Over-Year Growth in Q2 2026 1 – Minichart - Minichart
bioAffinity reports 200% jump in lung test sales year-over-year - Investing.com
bioAffinity Technologies Q2 CyPath® Lung Sales More Than Double Year‑Over‑Year - TradingView
CyPath Lung demand surges as bioAffinity (BIAF) Q2 2026 test volume more than triples - Stock Titan
bioAffinity Technologies (BIAF) Holds Near Support as Trading Volume Remains ElevatedNaked POC - dars.gov.et
BIAF Stock Gains As CyPath Sales Surge 146% In Q1 - Stocktwits
bioAffinity Technologies Inc Warrant 2022- on bioAffinity Financial Disclosures & SEC Filings - TradingView
bioAffinity Technologies Sees Record CyPath® Lung Test Sales, Expands Veteran Screening with Philips Partnership - Minichart
bioAffinity Technologies reports accelerated CyPath Lung sales, Philips partnership to boost veteran screening - TradingView
CyPath Lung sales surge as bioAffinity (NASDAQ: BIAF) expands pipeline - Stock Titan
bioAffinity Technologies Company Profile & Introduction - Moomoo
bioAffinity Technologies Inc (BIAF) Valuation: PE, PB & Fair Value Analysis - TradingKey
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells - BioSpace
bioAffinity Technologies reports skin cancer siRNA preclinical results - grafa.com
bioAffinity to present skin cancer treatment research - Investing.com
bioAffinity to present skin cancer treatment research By Investing.com - Investing.com South Africa
BIOAFFINITY TECHNOLOGIES INC (BIAF) Stock Chart - ChartMill
BioAffinity Technologies Closes $3.2 Million Public Offering - Moomoo
bioAffinity Technologies Raises $3.2M in Best-Efforts Offering, Signs Purchase and Placement Pacts - TradingView
bioAffinity Technologies Inc (BIAFW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
bioAffinity Technologies (NASDAQ: BIAF) raises $3.2M in stock and pre-funded warrant sale - Stock Titan
bioAffinity Technologies Announces Closing of $3.2 Million Offering - Quantisnow
WallachBeth Capital Announces Closing of bioAffinity Technologies $3.2 Million Offering - PR Newswire
bioAffinity Technologies closes $3.2M public offering By Investing.com - Investing.com Nigeria
bioAffinity Technologies closes $3.2M public offering - Investing.com
BIOAFFINITY TECHNOLOGIES ANNOUNCES CLOSING OF $3.2 MILLION OFFERING - Moomoo
bioAffinity Technologies Inc (BIAFW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
bioAffinity Technologies Inc (BIAFW) Institutional Confidence - TradingKey
bioAffinity Technologies Inc (BIAFW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
bioAffinity Technologies Inc (BIAFW) Valuation: PE, PB & Fair Value Analysis - TradingKey
bioAffinity (NASDAQ: BIAF) to sell 1.04M shares, up to 2.96M pre-funded warrants - Stock Titan
bioAffinity Technologies Inc (BIAF) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
bioAffinity Technologies Inc (BIAF) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
bioAffinity Technologies Inc (BIAF) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
bioAffinity Technologies closes $3.2 million public offering - scanx.trade
bioAffinity Technologies Inc (BIAF) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioAffinity Technologies Prices $3.2 Million Offering; Shares Drop 13% - Moomoo
bioAffinity Technologies (BIAF) Slides Nearly 12% – Testing Key Support at $0.79Impulse Wave - newsline.com
bioAffinity Technologies Inc (BIAF) Institutional Confidence - TradingKey
bioAffinity Technologies Inc (BIAF) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
bioAffinity Technologies Inc (BIAF) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
bioAffinity Technologies Inc (BIAF) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
bioAffinity Technologies prices $3.2M public offering By Investing.com - Investing.com India
bioAffinity Technologies prices $3.2M public offering - Investing.com UK
WallachBeth Capital Announces Pricing of bioAffinity Technologie - GuruFocus
WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.2 Million Offering - PR Newswire
bioAffinity Technologies Announces Pricing of $3.2 Million Offering - Business Wire
bioAffinity Technologies Inc (BIAFW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
bioAffinity Technologies Inc (BIAFW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
bioAffinity Technologies Inc (BIAFW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
[EFFECT] bioAffinity Technologies, Inc. SEC Filing - Stock Titan
0.50%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):